A detailed history of Qrg Capital Management, Inc. transactions in Innoviva, Inc. stock. As of the latest transaction made, Qrg Capital Management, Inc. holds 85,940 shares of INVA stock, worth $1.53 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
85,940
Previous 76,010 13.06%
Holding current value
$1.53 Million
Previous $1.25 Billion 33.13%
% of portfolio
0.02%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$16.33 - $20.04 $162,156 - $198,997
9,930 Added 13.06%
85,940 $1.66 Billion
Q2 2024

Jul 12, 2024

BUY
$14.4 - $16.4 $180,172 - $205,196
12,512 Added 19.7%
76,010 $1.25 Billion
Q1 2024

May 07, 2024

BUY
$14.56 - $16.78 $79,847 - $92,021
5,484 Added 9.45%
63,498 $968 Million
Q4 2023

Feb 07, 2024

BUY
$12.32 - $16.27 $21,818 - $28,814
1,771 Added 3.15%
58,014 $931 Million
Q3 2023

Nov 13, 2023

BUY
$12.37 - $13.89 $695,725 - $781,215
56,243 New
56,243 $731 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Qrg Capital Management, Inc. Portfolio

Follow Qrg Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qrg Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Qrg Capital Management, Inc. with notifications on news.